期刊文献+

地特胰岛素联合门冬胰岛素治疗妊娠期糖尿病疗效与安全性及对母婴结局的影响研究 被引量:8

Study on the Efficacy and Safety of Insulin Detemir Combined with Insulin Aspart in the Treatment of Gestational Diabetes and Its Impact on Maternal and Fetal Outcomes
在线阅读 下载PDF
导出
摘要 目的探讨妊娠期糖尿病(gestational diabetes mellitus,GDM)产妇应用地特胰岛素联合门冬胰岛素治疗的效果。方法选取2021年7月—2022年9月期间在平遥县人民医院进行分娩的GDM产妇66例为研究对象,按隐匿数字随机法分为单药组(33例,门冬胰岛素治疗),联合组(33例,门冬胰岛素+地特胰岛素治疗),观察记录两组血糖变化、胰岛素水平、母婴结局,进行比较分析。结果治疗前,两组患者血糖控制水平比较,差异无统计学意义(P>0.05);治疗后,联合组的空腹血糖(fasting plasma glucose,FPG)、餐后2 h血糖(2-hour postprandial blood glucose,2 hPG)、糖化血红蛋白(glycated hemoglobin,HbA1c)水平均低于单药组,差异有统计学意义(P<0.05);联合组的FPG达标、2 hFPG达标、FPG和2 hFPG均达标的时间均显著短于单药组,差异有统计学意义(P<0.05);联合组的自然分娩率为72.73%显著高于单药组的48.48%,差异有统计学意义(P<0.05);单药组的不良妊娠结局发生率(24.24%)高于联合组(9.09%),差异无统计学意义(P>0.05)。结论地特胰岛素联合门冬胰岛素治疗GDM患者,可以获得较为理想的血糖控制效果,能更快的使患者血糖达到理想的标准,自然分娩率更高。 Objective To explore the effect of insulin detemir combined with insulin aspart in the treatment of gestational diabetes mellitus(GDM).Methods 66 GDM women who gave birth in Pingyao County People's Hospital from July 2021 to September 2022 were selected as research objects.According to the concealed number random method,33 patients were divided into a single-drug group(treated with insulin aspart)and 33 patients were combination group(treated with insulin aspart+insulin detemir).Observed and recorded the data on blood sugar changes,insulin levels,and maternal and infant outcomes between the two groups for comparative analysis.Results Before treatment,there was no statistically significant difference in blood glucose control levels between the two groups(P>0.05).After treatment,the levels of fasting plasma glucose(FPG),2-hour postprandial blood glucose(2 hPG),and glycated hemoglobin(HbA1c)in the combination group were lower than those in the single-drug group,the difference was statistically significant(P<0.05).The time for FPG to reach the target,2 hPG to reach the target,and both FPG and 2 hPG to reach the target in the combination group were significantly shorter than those in the single-drug group,the difference were statistically significant(P<0.05).The natural delivery rate in the combination group was 72.73%,which was significantly higher than the 48.48%in the single-drug group,the difference was statistically significant(P<0.05).The incidence rate of adverse pregnancy outcomes in the single-drug group(24.24%)was higher than that in the combination group(9.09%),and the difference was statistically significant(P>0.05).Conclusion Insulin detemir combined with insulin aspart can achieve ideal blood sugar control effects in patients with GDM,and can bring patients'blood sugar to the ideal standard faster,and the natural delivery rate is higher.
作者 王霞 WANG Xia(Department of Obstetrics,Pingyao County People's Hospital,Jinzhong,Shanxi Province,031100 China)
出处 《糖尿病新世界》 2023年第18期113-116,共4页 Diabetes New World Magazine
关键词 妊娠期糖尿病 地特胰岛素 门冬胰岛素 母婴结局 Gestational diabetes Insulin detemir Insulin aspart Maternal and fetal outcomes
作者简介 王霞(1979-),女,本科,副主任医师,研究方向为产科及相关疾病诊治。
  • 相关文献

参考文献12

二级参考文献166

  • 1毕晶晶,陈娟.门冬胰岛素联合二甲双胍对妊娠期糖尿病患者的治疗效果及对其血清Cys C与Hcy水平的影响探讨[J].中国合理用药探索,2019,0(11):76-78. 被引量:15
  • 2杨美英,蔡文竹,莫小跃.医学营养干预联合胰岛素治疗妊娠期糖尿病孕妇疗效及对孕妇妊娠结局和营养状态的影响[J].智慧健康,2021,7(21):168-170. 被引量:6
  • 3Kahn CR.Joslin糖尿病学[M].14版.潘长玉,主译.北京:人民卫生出版社,2005:550-552.
  • 4中华医学会妇产科学分会产科学组,中华医学会围产医学分会妊娠合并糖尿病协作组.妊娠合并糖尿病临床诊断与治疗推荐指南(草案)[J].中华妇产科杂志,2007,42:426-428.
  • 5中华人民共和国国家卫生部.WS331-2011妊娠期糖尿病诊断[s]北京:中华人民共和国国家卫生部,2011.
  • 6International Association of Diabetes and Pregnancy 3tudy Groups Consensus Panel,Metzger BE,Gabbe SG, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy[J].Diabetes Care,2010,33:676-682.
  • 7International Diabetes Federation. Global Guideline on Pregnancy and Diabetes[S].Brussels: International Diabetes Federation,2009.
  • 8Walker JD. Diabetes in pregnancy:management of diabetes and its complications from pre-conception to the postnatal period. NICE guideline 63. London, March 2008[J]. Diabet Med, 2008, 25: 1025-1027.
  • 9Hoffman L,Nolan C,Wilson JD,et al.Gestational diabetes mellitus-management guidellnes.The Australasian Diabetes in Pregnancy Society[J].Med J Aust, 1998,169:93-97.
  • 10Canadian Diabetes Association.2008 CDA clinical practiceguidelines for the prevention and management of diabetes in Canada[J].Can J Diabetes,2008,32:S168-180.

共引文献1723

同被引文献76

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部